Bausch + Lomb (BLCO) said Tuesday that the preloaded enVista Envy full range of vision intraocular lenses are now commercially available in Europe.
A clinical trial in the US demonstrated that 86.1% of patients reported little to no trouble for dysphotopsia with the enVista Envy intraocular lenses, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.